Found: 56
Select item for more details and to access through your institution.
Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A Comparison of the Pharmacokinetics of Methylphenidate Extended‐Release Orally Disintegrating Tablets With a Reference Extended‐Release Formulation of Methylphenidate in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 151, doi. 10.1002/cpdd.362
- By:
- Publication type:
- Article
Serdexmethylphenidate/ dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorder.
- Published in:
- Frontiers in Psychiatry, 2023, p. 1, doi. 10.3389/fpsyt.2023.1193455
- By:
- Publication type:
- Article
Efficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive Disorder: Two Randomized Controlled Trials.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 290, n. 8, p. 1033, doi. 10.1001/jama.290.8.1033
- By:
- Publication type:
- Article
Crossover Study of Dexmethylphenidate-ER Versus Placebo in Pediatric ADHD.
- Published in:
- Psychiatric Times, 2005, p. 12
- By:
- Publication type:
- Article
Risk factors associated with newly diagnosed attention-deficit/hyperactivity disorder in adults: a retrospective case-control study.
- Published in:
- BMC Psychiatry, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12888-023-05359-7
- By:
- Publication type:
- Article
Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 4, p. 461, doi. 10.3390/jcm8040461
- By:
- Publication type:
- Article
Reliability and Validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy, Safety, and Tolerability of a Novel Methylphenidate Extended-Release Oral Suspension (MEROS) in ADHD.
- Published in:
- 2017
- By:
- Publication type:
- journal article
ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Effects of Lisdexamfetamine Dimesylate on Emotional Lability in Children 6 to 12 Years of Age With ADHD in a Double-Blind Placebo-Controlled Trial.
- Published in:
- Journal of Attention Disorders, 2014, v. 18, n. 2, p. 123, doi. 10.1177/1087054712448252
- By:
- Publication type:
- Article
Changes in Emotions Related to Medication Used to Treat ADHD. Part II: Clinical Approaches.
- Published in:
- Journal of Attention Disorders, 2011, v. 15, n. 2, p. 113, doi. 10.1177/1087054710381232
- By:
- Publication type:
- Article
Changes in Emotions Related to Medication Used to Treat ADHD. Part I: Literature Review.
- Published in:
- Journal of Attention Disorders, 2011, v. 15, n. 2, p. 101, doi. 10.1177/1087054710381230
- By:
- Publication type:
- Article
Treatment Preferences of Adult Patients with Attention-Deficit/Hyperactivity Disorder – A Discrete Choice Experiment.
- Published in:
- Patient Preference & Adherence, 2024, v. 18, p. 1651, doi. 10.2147/PPA.S467724
- By:
- Publication type:
- Article
The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Phase 3 Placebo-Controlled Trials.
- Published in:
- Neuropsychiatric Disease & Treatment, 2021, v. 17, p. 1751, doi. 10.2147/NDT.S312011
- By:
- Publication type:
- Article
Treatment patterns among children and adolescents with attention-deficit/hyperactivity disorder in the United States – a retrospective claims analysis.
- Published in:
- BMC Psychiatry, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12888-022-04188-4
- By:
- Publication type:
- Article
Reasons for treatment changes in adults with attention-deficit/hyperactivity disorder: a chart review study.
- Published in:
- BMC Psychiatry, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12888-022-04016-9
- By:
- Publication type:
- Article
The effects of lisdexamfetamine dimesylate on emotional lability in children aged 6–12 years with attention-deficit/hyperactivity disorder in a double-blind, placebo-controlled trial.
- Published in:
- European Child & Adolescent Psychiatry, 2010, v. 19, p. S78, doi. 10.1007/s00787-010-0117-5
- By:
- Publication type:
- Article
Effects of OROS Methylphenidate on Academic, Behavioral, and Cognitive Tasks in Children 9 to 12 Years of Age With Attention-Deficit/Hyperactivity Disorder.
- Published in:
- Clinical Pediatrics, 2011, v. 50, n. 4, p. 308, doi. 10.1177/0009922810394832
- By:
- Publication type:
- Article
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Review of Long-Acting Stimulant and Nonstimulant ADHD Pharmacotherapy in Canada.
- Published in:
- Journal of the Canadian Academy of Child & Adolescent Psychiatry, 2011, v. 20, p. S1
- By:
- Publication type:
- Article
An Open-Label Extension Study Assessing the Long-Term Safety and Efficacy of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
- Published in:
- CNS Drugs, 2024, v. 38, n. 11, p. 891, doi. 10.1007/s40263-024-01120-0
- By:
- Publication type:
- Article
Early Morning ADHD Symptoms and Functional Impairment: Impact on Patients and Caregivers, and Pharmacological Approaches to Management.
- Published in:
- CNS Drugs, 2023, v. 37, n. 1, p. 31, doi. 10.1007/s40263-022-00978-2
- By:
- Publication type:
- Article
Authors' Reply to Singh and Balasundaram: Comment on "A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder".
- Published in:
- CNS Drugs, 2022, v. 36, n. 12, p. 1333, doi. 10.1007/s40263-022-00967-5
- By:
- Publication type:
- Article
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
- Published in:
- CNS Drugs, 2022, v. 36, n. 8, p. 897, doi. 10.1007/s40263-022-00938-w
- By:
- Publication type:
- Article
Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
- Published in:
- CNS Drugs, 2015, v. 29, n. 4, p. 331, doi. 10.1007/s40263-015-0241-3
- By:
- Publication type:
- Article
Attention-Deficit/Hyperactivity Disorder with Inadequate Response to Stimulants: Approaches to Management.
- Published in:
- CNS Drugs, 2014, v. 28, n. 2, p. 121, doi. 10.1007/s40263-013-0130-6
- By:
- Publication type:
- Article
A Randomized, Double-Blind, Crossover Study of Once-Daily Dexmethylphenidate in Children with Attention-Deficit Hyperactivity Disorder: Rapid Onset of Effect.
- Published in:
- CNS Drugs, 2008, v. 22, n. 8, p. 693, doi. 10.2165/00023210-200822080-00006
- By:
- Publication type:
- Article
The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder.
- Published in:
- Journal of Autism & Developmental Disorders, 2020, v. 50, n. 9, p. 3233, doi. 10.1007/s10803-019-04120-y
- By:
- Publication type:
- Article
A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical Trials.
- Published in:
- Journal of Attention Disorders, 2024, v. 28, n. 8, p. 1186, doi. 10.1177/10870547241243155
- By:
- Publication type:
- Article
Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD.
- Published in:
- Journal of Attention Disorders, 2022, v. 26, n. 14, p. 1870, doi. 10.1177/10870547221106238
- By:
- Publication type:
- Article
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD.
- Published in:
- Journal of Attention Disorders, 2022, v. 26, n. 6, p. 857, doi. 10.1177/10870547211025610
- By:
- Publication type:
- Article
Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension.
- Published in:
- Journal of Attention Disorders, 2021, v. 25, n. 10, p. 1417, doi. 10.1177/1087054719896853
- By:
- Publication type:
- Article
The Time Course of Effect of Multilayer-Release Methylphenidate Hydrochloride Capsules: A Randomized, Double-Blind Study of Adults With ADHD in a Simulated Adult Workplace Environment.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study.
- Published in:
- Journal of Attention Disorders, 2020, v. 24, n. 2, p. 192, doi. 10.1177/1087054719864644
- By:
- Publication type:
- Article
Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Steady-State Bioavailability of Extended-Release Methylphenidate (MPH-MLR) Capsule vs. Immediate-Release Methylphenidate Tablets in Healthy Adult Volunteers.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 11, p. 795, doi. 10.1007/s40261-014-0234-x
- By:
- Publication type:
- Article
Healthcare resource utilization and costs associated with psychiatric comorbidities in pediatric patients with attention-deficit/hyperactivity disorder: a claims-based case-cohort study.
- Published in:
- Child & Adolescent Psychiatry & Mental Health, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s13034-024-00770-8
- By:
- Publication type:
- Article
Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study is the United States.
- Published in:
- BMC Psychiatry, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12888-024-05994-8
- By:
- Publication type:
- Article
Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study is the United States.
- Published in:
- BMC Psychiatry, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12888-024-05994-8
- By:
- Publication type:
- Article
Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD.
- Published in:
- NPJ Digital Medicine, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s41746-021-00429-0
- By:
- Publication type:
- Article
Practitioner Review: Emotional dysregulation in attention‐deficit/hyperactivity disorder – implications for clinical recognition and intervention.
- Published in:
- Journal of Child Psychology, 2019, v. 60, n. 2, p. 133, doi. 10.1111/jcpp.12899
- By:
- Publication type:
- Article
Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/ hyperactivity disorder: sex and age effects and effect size across the day.
- Published in:
- Child & Adolescent Psychiatry & Mental Health, 2010, v. 4, p. 32, doi. 10.1186/1753-2000-4-32
- By:
- Publication type:
- Article
Treatment Patterns Among Patients with Attention-Deficit/Hyperactivity Disorder and Comorbid Anxiety and/or Depression in the United States: A Retrospective Claims Analysis.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 5, p. 2265, doi. 10.1007/s12325-023-02458-5
- By:
- Publication type:
- Article
Reasons for Treatment Changes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Chart Review Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 12, p. 5487, doi. 10.1007/s12325-022-02329-5
- By:
- Publication type:
- Article
Gender Effects in the Efficacy of Racemic Amphetamine Sulfate in Children with Attention-Deficit/Hyperactivity Disorder.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Guanfacine Extended Release as Adjunctive Therapy to Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
- Published in:
- Advances in Therapy, 2012, v. 29, n. 5, p. 385, doi. 10.1007/s12325-012-0020-1
- By:
- Publication type:
- Article
Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article